Home › Compare › APTX vs STAG

APTX vs STAG: Dividend Comparison 2026

APTX yields 2083.33% · STAG yields 3.44%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 APTX wins by $14544499705.97M in total portfolio value
10 years
APTX
APTX
● Live price
2083.33%
Share price
$0.10
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$14544499705.99M
Annual income
$13,289,647,770,778,488.00
Full APTX calculator →
STAG
STAG Industrial Inc.
● Live price
3.44%
Share price
$36.09
Annual div
$1.24
5Y div CAGR
0.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$18.3K
Annual income
$462.22
Full STAG calculator →

Portfolio growth — APTX vs STAG

📍 APTX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAPTXSTAG
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, APTX + STAG cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
APTX pays
STAG pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

APTX
Annual income on $10K today (after 15% tax)
$177,083.33/yr
After 10yr DRIP, annual income (after tax)
$11,296,200,605,161,714.00/yr
STAG
Annual income on $10K today (after 15% tax)
$292.45/yr
After 10yr DRIP, annual income (after tax)
$392.89/yr
At 15% tax rate, APTX beats the other by $11,296,200,605,161,322.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of APTX + STAG for your $10,000?

APTX: 50%STAG: 50%
100% STAG50/50100% APTX
Portfolio after 10yr
$7272249853.00M
Annual income
$6,644,823,885,389,475.00/yr
Blended yield
91.37%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on STAG right now

APTX
Analyst Ratings
2
Buy
5
Hold
1
Sell
Consensus: Hold
Price Target
$1.00
+941.7% upside vs current
Range: $1.00 — $1.00
Altman Z
-14.5
Piotroski
1/9
STAG
Analyst Ratings
9
Buy
9
Hold
3
Sell
Consensus: Buy
Price Target
$45.00
+24.7% upside vs current
Range: $39.00 — $59.00
Altman Z
1.2
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

APTX buys
0
STAG buys
0
No recent congressional trades found for APTX or STAG in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAPTXSTAG
Forward yield2083.33% ✓3.44%
Annual dividend / share$2.00 ✓$1.24
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0.3% ✓
Portfolio after 10y$14544499705.99M ✓$18.3K
Annual income after 10y$13,289,647,770,778,488.00 ✓$462.22
Total dividends collected$14455710543.57M ✓$4.0K
Payment frequencyquarterlymonthly
SectorStockREIT
Analyst consensusHoldBuy
Analyst price target$1.00$45.00 ✓

Year-by-year: APTX vs STAG ($10,000, DRIP)

YearAPTX PortfolioAPTX Income/yrSTAG PortfolioSTAG Income/yrGap
1← crossover$219,033$208,333.33$10,665$345.09+$208.4K → APTX
2$4,499,033$4,264,667.71$11,364$357.70+$4.49M → APTX
3$86,681,257$81,867,291.39$12,098$370.43+$86.67M → APTX
4$1,566,868,240$1,474,119,294.47$12,869$383.28+$1566.86M → APTX
5$26,579,804,805$24,903,255,789.01$13,677$396.23+$26579.79M → APTX
6$423,253,588,633$394,813,197,491.25$14,524$409.27+$423253.57M → APTX
7$6,328,542,537,504$5,875,661,197,666.76$15,411$422.41+$6328542.52M → APTX
8$88,877,753,676,302$82,106,213,161,172.67$16,339$435.61+$88877753.66M → APTX
9$1,172,758,817,952,321$1,077,659,621,518,678.10$17,311$448.89+$1172758817.94M → APTX
10$14,544,499,705,987,470$13,289,647,770,778,488.00$18,327$462.22+$14544499705.97M → APTX

APTX vs STAG: Complete Analysis 2026

APTX — Stock

Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic peripheral neuropathy, as well as in Phase II/b clinical trial for treating fibromyalgia. It is also developing NYX-783, an N-methyl-D-aspartate receptors (NMDAr) modulator that is in Phase II/b clinical trial to treat post-traumatic stress disorder; and NYX-458, an NMDAr modulator, which is in Phase II clinical study for the treatment of Parkinson's disease cognitive impairment. The company has a research collaboration agreement with Allergan plc. Aptinyx Inc. was incorporated in 2015 and is headquartered in Evanston, Illinois.

Full APTX Calculator →

STAG — REIT

STAG Industrial, Inc. (NYSE: STAG) is a real estate investment trust focused on the acquisition and operation of single-tenant, industrial properties throughout the United States. By targeting this type of property, STAG has developed an investment strategy that helps investors find a powerful balance of income plus growth.

Full STAG Calculator →
📬

Get this APTX vs STAG comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

APTX vs SCHDAPTX vs JEPIAPTX vs OAPTX vs KOAPTX vs MAINAPTX vs PLDAPTX vs EQRAPTX vs VICI

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.